Zinc-containing Vaginal Gel and Oral Fluconazole for Vulvovaginal Candidiasis.
Status:
Recruiting
Trial end date:
2025-01-07
Target enrollment:
Participant gender:
Summary
Vaginitis is one of the most common gynecological problems in women. Candida albicans is
responsible for more than 85% of vaginal fungal infections and reinfection after standard
treatment is quite common. The aim of this study is to compare the effects of a
zinc-containing vaginal gel and oral fluconazole on the treatment and recurrence of
vulvovaginal candidiasis (VVC). The investigator's hypothesis is that zinc-containing vaginal
gel may decrease the rate of reinfection after standard treatment with oral 150 mg
fluconazole.